Dentium (A145720) Q1 2025 earnings summary

Executive summary

• Maintains a leading position in dental medical devices and implants, with a focus on digital dentistry and global expansion; 79% of sales are overseas, operating 23 consolidated subsidiaries.

• Recently diversified into hydrogen fuel cell energy, leveraging zirconia technology from dental applications.

• Holds the second-largest market share in Korea (21%) and sixth globally (5%), with China as a key growth market.

Financial highlights

• 2024 revenue reached KRW 407.8 billion, up from KRW 393.2 billion in 2023; Q1 2025 revenue was KRW 76.8 billion, with net income of KRW 12.7 billion.

• Operating income for 2024 was KRW 98.5 billion, down from KRW 138.3 billion in 2023; Q1 2025 operating income was KRW 9.6 billion.

• Net income for 2024 was KRW 72.4 billion, compared to KRW 96.5 billion in 2023.

• Cash and cash equivalents at Q1 2025 end: KRW 100.9 billion; total assets: KRW 900.5 billion.

• Dividend payout increased to KRW 5,174 million in 2025 from KRW 3,450 million in 2024.

Outlook and guidance

• Targets global top 3 position by 2031, focusing on advanced markets, economies of scale, and digital dentistry.

• Plans for 20% annual sales growth through 2030, driven by digital dentistry and new product launches.

• Hydrogen fuel cell business (SOFC) expected to begin production and revenue recognition after 2026, with new facilities under construction in Vietnam.